Stay clear of concomitant use of tucatinib with CYP3A substrates, exactly where minimum concentration adjustments may well produce serious or life-threatening toxicities. If unavoidable, reduce CYP3A substrate dose In accordance with merchandise labeling.Drug conversation with fluoxetine A multiple-dose study was executed to assess the result of fl